IRL management are desperately trying to excite investors with the anticipation of the Aravalli lead/zinc project. In fact is this is the only project that IRL has a connection with that has any worthwhile attributes, however unfortunately this project maybe years or decades away from fruition. If at all, judging from the latest HZL Revision Applications.
Investors be prepared for a .003c to .005c IRL share price for 2016 as IRL offers little to no upside in the near term.
The Surda mine contract is an absolute disaster, you only need to look at IRL's own presentation to see how successful the HCL Surda contract is.
Good work boys, maybe everyone should buy shares in HCL.
In years to come University professors will be teaching students how NOT to lose money and IRL will be a prime candidate for this lecture.
Next we have the Rakha mine contract, most likely the same Directors signed off on this project as the Surda Contract and the Prism Cement contract.
Thats if it ever happens, however it might be more profitable if it never happens especially if its a repeat of the Surda contract or the Prism Cement contract.
Wow boys, we've only been waiting 30 months for this supposedly good contract.
You have to remember that this is result of very hard work from our dedicated management team.
"result of much hard work by a dedicated management team over the past 5 years"
I'd hate to imagine the result if IRL management didn't work hard, but isn't that what we pay them for.
I'm sure anybody would be happy with $800,000 pa for these results.
But doesn't everybody work hard? My sister-in-law in Thailand works 16 hours a day and 7 days a week, 52 weeks of the year, she owns a small shop and only employs 2 people, but she makes more profit in one week than IRL has made in 8 YEARS. She never tells me how hard she works, unlike some other people.
Maybe IRL should open a few Indian restaurants in Sydney, Brisbane and Melbourne, its about the only way they'll ever make a profit.
Its been suggested.
IRL Price at posting:
0.4¢ Sentiment: Sell Disclosure: Held